How to cite item

Epidermal growth factor tyrosine kinase inhibitor therapy inferior to second-line chemotherapy in EGFR wild-type non-small cell lung cancer patients: results of French nationwide observational study

   
@article{TLCR17380,
	author = {Aaron Lisberg and Edward B. Garon},
	title = {Epidermal growth factor tyrosine kinase inhibitor therapy inferior to second-line chemotherapy in EGFR wild-type non-small cell lung cancer patients: results of French nationwide observational study},
	journal = {Translational Lung Cancer Research},
	volume = {6},
	number = {Suppl 1},
	year = {2017},
	keywords = {},
	abstract = {In the recent issue of The European Respiratory Journal, Tomasini et al. report on an observational study comparing the clinical, biological, treatment and outcome data for epidermal growth factor wild-type (EGFR-wt) advanced non-small cell lung cancer (NSCLC) patients who received second-line treatment with an EGFR tyrosine kinase inhibitor (TKI) versus those that received second-line chemotherapy, collected in France over a 1 year period (1). Their central finding, that clinical outcomes with second-line EGFR TKI therapy in EGFR-wt patients were inferior to those with second-line chemotherapy, underscores the ineffectual nature of the treatment of EGFR-wt NSCLC with an EGFR TKI.},
	issn = {2226-4477},	url = {https://tlcr.amegroups.org/article/view/17380}
}